Project Grant R43CK000714

The Department of Health and Human Services Centers for Disease Control and Prevention awarded Microsensor Labs, LLC $306,872 on September 1, 2026, to develop a high-throughput automated platform for rapid isolation and testing of Salmonella. The award, made under CFDA 93.318 (Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security), runs through August 31, 2027, with place of performance in Illinois. The project is classified...

The Centers for Disease Control and Prevention awarded $613,744 to SKM Instruments, Inc. on September 30, 2025, under the Prevention of Disease, Disability, and Death by Infectious Diseases program (CFDA 93.084) to develop an ultra-rapid optical platform for antimicrobial susceptibility testing of pulmonary non-tuberculous mycobacterial infections. Performance occurs in Wyoming, with a period of performance extending through May 31, 2026. The project grant supports the development of...

The Centers for Disease Control and Prevention awarded Esper Biosciences Inc. $614,000 on September 30, 2025, under the CDC Investigations and Technical Assistance program (CFDA 93.283) to develop a rapid point-of-care nucleic acid test for hepatitis C using nanosensors. The award period runs through September 29, 2026, with performance at Esper Biosciences' location in Ithaca, New York. The CDC Investigations and Technical Assistance program supports efforts to control communicable diseases,...

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award supports the development of a novel device that can rapidly and automatically extract pathogen DNA from whole blood samples to enable faster diagnosis of sepsis. The $274,858 award to New England Hemolytics, Inc., with a project period from September 1, 2024 to February 28, 2025, will fund the testing and optimization of this technology across common sepsis-causing pathogens. The...

Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Massachusetts General Hospital $473,937 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 25, 2025, for a project period extending through June 30, 2027. The award supports development of a novel point-of-care liquid biopsy diagnostic tool for early detection of sepsis-associated organ damage. The project leverages the institution's pioneering liquid biopsy...

The Centers for Disease Control and Prevention awarded Nanohmics Inc. $1,825,723 on September 30, 2025, under the CDC Investigations and Technical Assistance program (CFDA 93.283) to develop lateral flow-electrochemiluminescent test strips and a portable reader for ultrasensitive detection of foodborne pathogens. Performance occurs in Austin, Texas, with a completion date of September 29, 2027. The project grant supports research and development of diagnostic detection technology intended to...

Federal Project Grant Award Summary Pace Diagnostics, Inc. received a $600,000 Project Grant from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283), awarded on September 30, 2025, with a completion date of March 31, 2026. The award supports the development of an ultrasensitive urine-based tuberculosis (TB) antigen rapid detection test for diagnosing active tuberculosis. This diagnostic tool represents the program's...

The National Institute of Allergy and Infectious Diseases awarded Helixbind, Inc. $1,029,859 on July 16, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to advance development of an automated molecular diagnostic system for rapid characterization of bloodstream infections directly from whole blood. Helixbind is developing a sample-to-answer assay that identifies pathogens causing sepsis and antimicrobial-resistant organisms within approximately four hours,...

The Centers for Disease Control and Prevention awarded Hava Inc. $455,409 under the Centers for Disease Control and Prevention Investigations and Technical Assistance program (CFDA 93.283) on September 1, 2026, to develop rapid production methods for metal organic framework fabrics for air filtration. The award supports a project period of performance extending through August 31, 2028, with work performed in Albemarle County, Virginia. The CFDA 93.283 program assists state and local health...

The Centers for Disease Control and Prevention awarded Seacoast Science, Inc. $1.05 million on September 30, 2025, under the CDC Investigations and Technical Assistance program (CFDA 93.283) to develop an auto-calibrating air quality monitoring system. The award funds development of an automated monitoring system capable of self-calibration for air quality measurement. Seacoast Science, Inc., a Carlsbad, California-based manufacturer of advanced chemical sensors and detection devices, will...